Anirban Maitra Highlights New MSK Cancer Center Study on Data Integration
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared a study conducted by Justin Jee et al. on X, adding his own thoughts:
“Amazing new study from MSK Cancer Center Cancer Data Science Initiative Group in Nature
Automated real-world data integration improves cancer outcome prediction
Structured medication, demographic, tumor registry, and tumor genomic data from almost 25,000 patients (MSK-CHORD), including 3,100 patients with Pancreatic Cancer, and using NLP to predict outcomes.
>700,000 radiology reports in this model (!) to predict sites of metastases.”
Automated real-world data integration improves cancer outcome prediction
Authors: Justin Jee, Christopher Fong, Karl Pichotta, Thinh Ngoc Tran, Anisha Luthra, Michele Waters, Chenlian Fu, Mirella Altoe, Si-Yang Liu, Steven B. Maron, Mehnaj Ahmed, Susie Kim, Mono Pirun, Walid K. Chatila, Ino de Bruijn, Arfath Pasha, Ritika Kundra, Benjamin Gross, Brooke Mastrogiacomo, Tyler J. Aprati, David Liu, JianJiong Gao, Marzia Capelletti, Kelly Pekala, Lisa Loudon, Maria Perry, Chaitanya Bandlamudi, Mark Donoghue, Baby Anusha Satravada, Axel Martin, Ronglai Shen, Yuan Chen, A. Rose Brannon, Jason Chang, Lior Braunstein, Anyi Li, Anton Safonov, Aaron Stonestrom, Pablo Sanchez-Vela, Clare Wilhelm, Mark Robson, Howard Scher, Marc Ladanyi, Jorge S. Reis-Filho, David B. Solit, David R. Jones, Daniel Gomez, Helena Yu, Debyani Chakravarty, Rona Yaeger, Wassim Abida, Wungki Park, Eileen M. O’Reilly, Julio Garcia-Aguilar, Nicholas Socci, Francisco Sanchez-Vega, Jian Carrot-Zhang, Peter D. Stetson, Ross Levine, Charles M. Rudin, Michael F. Berger, Sohrab P. Shah, Deborah Schrag, Pedram Razavi, Kenneth L. Kehl, Bob T. Li, Gregory J. Riely, Nikolaus Schultz & MSK Cancer Data Science Initiative Group
Dr. Anirban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center. He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.
Read more posts featuring Anirban Maitra.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023